190 related articles for article (PubMed ID: 33767265)
1. Degradation of insulin amyloid by antibiotic minocycline and formation of toxic intermediates.
Mori W; Yuzu K; Lobsiger N; Nishioka H; Sato H; Nagase T; Iwaya K; Lindgren M; Zako T
Sci Rep; 2021 Mar; 11(1):6857. PubMed ID: 33767265
[TBL] [Abstract][Full Text] [Related]
2. Differences in interaction lead to the formation of different types of insulin amyloid.
Mori W; Kawakami R; Niko Y; Haruta T; Imamura T; Shiraki K; Zako T
Sci Rep; 2022 May; 12(1):8556. PubMed ID: 35595809
[TBL] [Abstract][Full Text] [Related]
3. Toxicity of insulin-derived amyloidosis: a case report.
Iwaya K; Zako T; Fukunaga J; Sörgjerd KM; Ogata K; Kogure K; Kosano H; Noritake M; Maeda M; Ando Y; Katsura Y; Nagase T
BMC Endocr Disord; 2019 Jun; 19(1):61. PubMed ID: 31196059
[TBL] [Abstract][Full Text] [Related]
4. Insulin amyloid polymorphs: implications for iatrogenic cytotoxicity.
Yuzu K; Lindgren M; Nyström S; Zhang J; Mori W; Kunitomi R; Nagase T; Iwaya K; Hammarström P; Zako T
RSC Adv; 2020 Oct; 10(62):37721-37727. PubMed ID: 35515176
[TBL] [Abstract][Full Text] [Related]
5. [Insulin-derived amyloidosis (insulin ball) and skin-related complications of insulin therapy].
Nagase T; Iwaya K; Zako T; Kikuchi M; Katsura Y
Nihon Yakurigaku Zasshi; 2023; 158(2):173-177. PubMed ID: 36858501
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo insulin amyloid degradation mediated by Serratiopeptidase.
Metkar SK; Girigoswami A; Murugesan R; Girigoswami K
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):728-735. PubMed ID: 27770948
[TBL] [Abstract][Full Text] [Related]
7. A feline model of experimentally induced islet amyloidosis.
Hoenig M; Hall G; Ferguson D; Jordan K; Henson M; Johnson K; O'Brien T
Am J Pathol; 2000 Dec; 157(6):2143-50. PubMed ID: 11106586
[TBL] [Abstract][Full Text] [Related]
8. Turmeric effect on subcutaneous insulin-induced amyloid mass: an in vivo study.
Kheirbakhsh R; Chinisaz M; Amanpour S; Amini S; Khodayari S; Khodayari H; Dilmaghanian A; Haddadi M; Ebrahim-Habibi A
Drug Chem Toxicol; 2017 Jan; 40(1):1-6. PubMed ID: 27079769
[TBL] [Abstract][Full Text] [Related]
9. Current insight in the localized insulin-derived amyloidosis (LIDA): clinico-pathological characteristics and differential diagnosis.
Ansari AM; Osmani L; Matsangos AE; Li QK
Pathol Res Pract; 2017 Oct; 213(10):1237-1241. PubMed ID: 28935176
[TBL] [Abstract][Full Text] [Related]
10. Minocycline does not affect amyloid beta phagocytosis by human microglial cells.
Familian A; Eikelenboom P; Veerhuis R
Neurosci Lett; 2007 Apr; 416(1):87-91. PubMed ID: 17317005
[TBL] [Abstract][Full Text] [Related]
11. Blended polar/nonpolar peptide conjugate interferes with human insulin amyloid-mediated cytotoxicity.
Sen S; Singh P; Mishra NK; Ganesh S; Sivakumar S; Verma S
Bioorg Chem; 2021 Jun; 111():104899. PubMed ID: 33882365
[TBL] [Abstract][Full Text] [Related]
12. Insulin adsorption onto zinc oxide nanoparticle mediates conformational rearrangement into amyloid-prone structure with enhanced cytotoxic propensity.
Asthana S; Hazarika Z; Nayak PS; Roy J; Jha AN; Mallick B; Jha S
Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):153-166. PubMed ID: 30315849
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of minocycline on amyloid beta fibril formation and human microglial activation.
Familian A; Boshuizen RS; Eikelenboom P; Veerhuis R
Glia; 2006 Feb; 53(3):233-40. PubMed ID: 16220550
[TBL] [Abstract][Full Text] [Related]
14. Severe insulin resistance associated with subcutaneous amyloid deposition.
Albert SG; Obadiah J; Parseghian SA; Yadira Hurley M; Mooradian AD
Diabetes Res Clin Pract; 2007 Mar; 75(3):374-6. PubMed ID: 16930758
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous amyloidoma models for screening potential anti-fibrillating agents in vivo.
Das D; Paul A; Maity SK; Chatterjee S; Chakrabarti P
STAR Protoc; 2021 Dec; 2(4):101027. PubMed ID: 34977673
[TBL] [Abstract][Full Text] [Related]
16. Minocycline attenuates Aβ oligomers-induced pro-inflammatory phenotype in primary microglia while enhancing Aβ fibrils phagocytosis.
El-Shimy IA; Heikal OA; Hamdi N
Neurosci Lett; 2015 Nov; 609():36-41. PubMed ID: 26472705
[TBL] [Abstract][Full Text] [Related]
17. Peptide Inhibitors of Insulin Fibrillation: Current and Future Challenges.
Rosetti B; Marchesan S
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674821
[TBL] [Abstract][Full Text] [Related]
18. Deciphering the enhanced inhibitory, disaggregating and cytoprotective potential of promethazine towards amyloid fibrillation.
Nusrat S; Zaman M; Masroor A; Siddqi MK; Zaidi N; Neelofar K; Abdelhameed AS; Khan RH
Int J Biol Macromol; 2018 Jan; 106():851-863. PubMed ID: 28823512
[TBL] [Abstract][Full Text] [Related]
19. Investigation of factors that cause insulin precipitation and/or amyloid formation in insulin formulations.
Ohno Y; Seki T; Kojima Y; Miki R; Egawa Y; Hosoya O; Kasono K; Seki T
J Pharm Health Care Sci; 2019; 5():22. PubMed ID: 31687164
[TBL] [Abstract][Full Text] [Related]
20. Amyloid by Design: Intrinsic Regulation of Microbial Amyloid Assembly.
Deshmukh M; Evans ML; Chapman MR
J Mol Biol; 2018 Oct; 430(20):3631-3641. PubMed ID: 30017921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
